Seoul, Korea South
DAYLI Partners is a leading venture capital firm specialized in the bio-healthcare industry. We discover, build, and invest in next-generation life science companies, ranging from early to pre-IPO stage. DAYLI Partners Team Our investment professionals possess strong scientific, medical, legal and financial expertise. By our solid network over industry, university, laboratory, and hospital, we identify opportunities to discover next-generation leading life science companies.
47
Total Investments
39
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About DAYLI Partners
Recent Investments (47)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2024 | |
| Convertible Note | •••••• | Oct 2023 | |
| Series B | •••••• | Oct 2023 | |
| Series B | •••••• | Sep 2023 | |
| Series A | •••••• | Jan 2023 | |
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Series A | •••••• | Jan 2023 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Series A - K | •••••• | Jan 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
